Skip to main content
main-content

Zeitschrift

Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology 5/2021

Ausgabe 5/2021

Inhaltsverzeichnis ( 15 Artikel )

20.03.2021 | Review Article | Ausgabe 5/2021

Anticancer potential of metformin: focusing on gastrointestinal cancers

Mohammad rafi Khezri, Hassan Melekinejad, Naime Majidi-Zolbanin, Morteza Ghasemnejad-Berenji

25.01.2021 | Original Article | Ausgabe 5/2021

A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies

Katharine A. Collier, Hugo Valencia, Herbert Newton, Erinn M. Hade, Douglas W. Sborov, Robert Cavaliere, Ming Poi, Mitch A. Phelps, Sophia G. Liva, Christopher C. Coss, Jiang Wang, Soun Khountham, Paul Monk, Charles L. Shapiro, Richard Piekarz, Craig C. Hofmeister, D. Bradley Welling, Amir Mortazavi

26.01.2021 | Original Article | Ausgabe 5/2021

A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumours

Sunit Sarkar, Ben Tran, Lisa Horvath, Michael Lam, Peter Savas, Peter Grimison, James R. Whittle, James C. Kuo, Nicole Signal, David Edmonds, Philip Hogg, Danny Rischin, Jayesh Desai, Anne Hamilton

28.01.2021 | Original Article | Ausgabe 5/2021 Open Access

Extrapolation of pharmacokinetics and pharmacodynamics of sunitinib in children with gastrointestinal stromal tumors

Reza Khosravan, Steven G. DuBois, Katherine Janeway, Erjian Wang

02.02.2021 | Original Article | Ausgabe 5/2021 Open Access

Evaluating clinical impact of a shortened infusion duration for ramucirumab: a model-based approach

Ling Gao, Yiu-Keung Lau, Ran Wei, Lisa O’Brien, Amanda Long, Yongzhe Piao, Paolo Abada

05.02.2021 | Original Article | Ausgabe 5/2021

Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway

Xianglan Yi, Liping Lou, Jun Wang, Jing Xiong, Sheng Zhou

05.02.2021 | Original Article | Ausgabe 5/2021

Preemptive screening of DPYD as part of clinical practice: high prevalence of a novel exon 4 deletion in the Finnish population

Jatta Saarenheimo, Nesna Wahid, Natalja Eigeliene, Ravichandra Ravi, Gajja S. Salomons, Matilde Fernandez Ojeda, Raymon Vijzelaar, Antti Jekunen, André B. P. van Kuilenburg

08.02.2021 | Original Article | Ausgabe 5/2021 Open Access

Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)

Keiichiro Ishibashi, Toru Aoyama, Masahito Kotaka, Hironaga Satake, Yasushi Tsuji, Masato Kataoka, Masato Nakamura, Naoki Nagata, Junichi Sakamoto, Koji Oba, Hideyuki Mishima

14.02.2021 | Original Article | Ausgabe 5/2021

Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer

Filipa Lynce, James T. Williams, Meredith M. Regan, Craig A. Bunnell, Rachel A. Freedman, Sara M. Tolaney, Wendy Y. Chen, Erica L. Mayer, Ann H. Partridge, Eric P. Winer, Beth Overmoyer

14.02.2021 | Original Article | Ausgabe 5/2021

Carboxylesterase 1 polymorphisms are associated with clinical outcomes in gastroenteric cancer patients treated with capecitabine

Duo Liu, Xuehua Li, Xiang Li, Huiqi Wang, Mei Dong

17.02.2021 | Original Article | Ausgabe 5/2021 Open Access

Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer

Chao Li, Lowell Hart, Taofeek K. Owonikoko, Raid Aljumaily, Caio Max Rocha Lima, Paul R. Conkling, Roy Timothy Webb, Robert M. Jotte, Steven Schuster, William J. Edenfield, Deborah A. Smith, Mark Sale, Patrick J. Roberts, Rajesh K. Malik, Jessica A. Sorrentino

21.02.2021 | Original Article | Ausgabe 5/2021

Early myelostimulation in patients with locally advanced gastric cancer after fluorouracil plus platinum-based neoadjuvant chemotherapy is related to poor prognosis

Yang Liu, Yongde Cao, Leting Xiao, Haijiang Wang

09.03.2021 | Short Communication | Ausgabe 5/2021

Comparison of a thymine challenge test and endogenous uracil–dihydrouracil levels for assessment of fluoropyrimidine toxicity risk

Kathryn E. Burns, Ottiniel Chavani, Soo Hee Jeong, John A. Duley, David Porter, Michael Findlay, R. Matthew Strother, Nuala A. Helsby

09.03.2021 | Letter to the Editor | Ausgabe 5/2021

Detecting DPD deficiency: when perfect is the enemy of good

Joseph Ciccolini, Gérard Milano, Henk-Jan Guchelaar

26.10.2020 | Retraction Note | Ausgabe 5/2021

Retraction Note to: Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR‑181 level

Anjing Gong, Na Ge, Weicheng Yao, Luxiang Lu, Hui Liang

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise